Standardization within the consortium Cancer consortia
description
Transcript of Standardization within the consortium Cancer consortia
Standardization within the consortium
Cancer consortiaPaolo Boffetta
IARC
IARC-coordinated cancer consortia
• INTERLYMPH– >20 case-control studies of
lymphoma• ILCCO
– >40 case-control and cohort studies of lung cancer
• INHANCE– ~20 case-control studies of head and
neck cancer
Characteristics of IARC cancer consortia
• Emphasis on pooling of independently collected results
• Coordinated generation of new data• Projects proposed and managed by
working groups• Light central coordination• Expansion to low- and medium-
resource countries
Data flow
• No central facility for data management and analysis
• A common database has accumulated starting with the initial pooled analyses and including more and more data
• Contacts between people involved in subsequent analyses
Phenotype standardizationExample of InterLymph
• Pathological and genetic heterogeneity• Background
– reviews conducted within studies– need for network-wide review?
• Pathology working group– epidemiology-oriented classification
• hierarchical
– limited review (5• % of 10,000 cases)
Data flow - Steps
• Collection of study protocols, questionnaires and other forms– posted on website
• Data provided by PI– specific vs. free data format
• Checking and cleaning of data• Pooled analysis
– performed by working group– detailed preliminary results circulated among PI– test of heterogeneity among studies, sensitivity
analyses
Pooled AnalysesHead & Neck Cancer SNP
• 11 SNPs in metabolic genes, 7 in DNA repair genes • 10 case-control studies from the US and Europe • Request % undetermined and % concordance for
quality controls from each study• Test for heterogeneity by:
– Laboratory sources: genotyping method, source of DNA – Study characteristics: hospital vs. population-based, study
period, sample size – Other: ethnicity, age, smoking, alcohol drinking, subsite
• Standardization – adjust for variables that contribute to heterogeneity, present overall OR and stratified OR
Novel analysesImmunological SNP in
InterLymph• Selection of a list of relevant SNP
– 12 SNP related to immunological response
• Analysis of DNA samples in five laboratories– four used Taqman– one used Pyrosequencing or allele-specific PCR
• Quality control– 102 DNA samples from ethnically diverse
individuals that previously had been sequenced and genotyped (SNP500Cancer project)
– assays not in Hardy Weinberg Equilibrium (HWE) among controls were re-checked
Rothman et al., submitted